DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 3ACEPHEN
02 1ACETAMINOPHEN
03 4ALCLOMETASONE DIPROPIONATE
04 1ALTOPREV
05 3AMMONIUM LACTATE
06 1ASPIRIN AND DIPYRIDAMOLE
07 1AZELEX
08 1CANDESARTAN CILEXETIL
09 1CHLORPROMAZINE HYDROCHLORIDE
10 2CLARITHROMYCIN
11 3CLINDAMYCIN PHOSPHATE
12 1CLINDESSE
13 5CLOBETASOL PROPIONATE
14 1COMPRO
15 1CORDRAN
16 1DESONIDE
17 4DICLOFENAC SODIUM
18 4DIFLORASONE DIACETATE
19 1ELIMITE
20 1EPIFOAM
21 13ESOMEPRAZOLE MAGNESIUM
22 1ESOMEPRAZOLE STRONTIUM
23 1ESTRADIOL
24 2EURAX
25 1EXELDERM
26 2FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE
27 6FLUOCINONIDE
28 1FLURANDRENOLIDE
29 1GLIPIZIDE
30 1HYCAMTIN
31 4HYDROCORTISONE
32 1IBUPROFEN SODIUM
33 1IMPOYZ
34 1INFANTS FEVERALL
35 1KYNMOBI
36 1LIDEX
37 2LINDANE
38 1LORATADINE AND PSEUDOEPHEDRINE SULFATE
39 1LOTRIMIN ULTRA
40 1MELOXICAM
41 1MENTAX
42 2METOPROLOL SUCCINATE
43 1MICONAZOLE 3 COMBINATION PACK
44 3MICONAZOLE NITRATE
45 1MICONAZOLE NITRATE COMBINATION PACK
46 4MUPIROCIN
47 1MYKACET
48 1NAPROXEN AND ESOMEPRAZOLE MAGNESIUM
49 2NEXIUM
50 1NEXIUM 24HR
51 1NITROGLYCERIN
52 1NITROSTAT
53 5NYSTATIN
54 3NYSTATIN AND TRIAMCINOLONE ACETONIDE
55 1OMEPRAZOLE
56 3OMEPRAZOLE MAGNESIUM
57 1PANDEL
58 2PERMETHRIN
59 1PIMECROLIMUS
60 2PRILOSEC
61 1PRILOSEC OTC
62 1PROCHLORPERAZINE
63 1PROMETHAZINE HYDROCHLORIDE
64 4RANITIDINE HYDROCHLORIDE
65 1TAMSULOSIN HYDROCHLORIDE
66 1TOLAK
67 1TRI-LUMA
68 3TRIAMCINOLONE ACETONIDE
69 1VANIQA
70 1VANOS
71 1VIMOVO
72 1YOSPRALA
73 1ZONALON
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Drug : ESOMEPRAZOLE MAGNESIUM
Dosage Form : CAPSULE, DELAYED REL PELLETS; ORAL
Application Number : 78279
Country : US
Patented : No
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Drug : ESOMEPRAZOLE MAGNESIUM
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 211571
Country : US
Patented : No
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Drug : RANITIDINE HYDROCHLORIDE
Dosage Form : TABLET; ORAL
Application Number : 209161
Country : US
Patented : No
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Drug : RANITIDINE HYDROCHLORIDE
Dosage Form : TABLET; ORAL
Application Number : 210010
Country : US
Patented : No
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Drug : RANITIDINE HYDROCHLORIDE
Dosage Form : TABLET; ORAL
Application Number : 209160
Country : US
Patented : No
LOOKING FOR A SUPPLIER?
